<DOC>
	<DOCNO>NCT01193504</DOCNO>
	<brief_summary>The purpose study determine Lotemax eye drop least effective Pred Forte eye drop , standard care cataract surgery .</brief_summary>
	<brief_title>Randomized , Masked Comparison Bromfenac Besifloxacin BID With Either Prednisolone BID Loteprednol 0.5 % BID Prevention Retinal Thickening CME Following Phacoemulsification</brief_title>
	<detailed_description>Prednisolone 1 % , topical steroid , consider standard care follow cataract surgery reduce inflammation . We aim determine Lotemax least effective Prednisolone . If , finding would demonstrate physician treatment option consider .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Pseudophakia</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Loteprednol Etabonate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>7- ( 3-aminohexahydro-1H-azepin-1-yl ) -8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>Male female &gt; 18 year age schedule undergo cataract surgery Patients systemic disease enrol ocular manifestation disease ( e.g . diabetic normal retinal exam ) Expected visual outcome BCVA ( best correct visual acuity ) &gt; 20/25 postoperatively , determine potential visual acuity test review preoperative corneal topography OCT ( optical coherence tomography ) . Ability provide inform consent , take study medication direct , likely complete study visit Known contraindication study medication component Required use ocular medication study medication study Evidence macular disease ( Epiretinal membrane , Vitreomacular traction syndrome , macular hole ) preoperative OCT ( optical coherence tomography ) Presence significant dry macular degeneration may impact postoperative visual result . History retinal vein occlusion diabetic macular edema , uveitis macular disease predispose cystoid macular edema prolong intraocular inflammation . Posterior capsule rupture , Vitreous loss surgery complication surgeon 's opinion , could reduce potential target visual outcome Anticipated need mechanical iris dilate device Presence Epithelial Basement Membrane Dystrophy , significant dry eye , significant blepharitis , corneal condition may impact BCVA ( best correct visual acuity ) postoperatively</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Prevention Retinal Thickening CME Following Phacoemulsification</keyword>
	<keyword>Pseudophakia follow cataract surgery</keyword>
</DOC>